To improve the treatment of spondyloarthritis by managing the standard application of targeted therapy drugs in China.
10.3760/cma.j.cn112138-20221031-00807
- Author:
Xin Ping TIAN
1
;
Xiao Feng ZENG
1
Author Information
1. Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital,Peking Union Medical College,Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases, Ministry of Science & Technology, State Key Laboratory of Complex Severe and Rare Diseases, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China.
- Publication Type:Journal Article
- MeSH:
Humans;
Spondylarthritis/drug therapy*;
Spondylitis, Ankylosing/drug therapy*;
China
- From:
Chinese Journal of Internal Medicine
2023;62(6):587-589
- CountryChina
- Language:Chinese
